Inhibition of VEGF-R2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function

被引：0
|
作者：
Villalta, S. [1 ]
Lang, Jiena [1 ]
Kubeck, Samantha [1 ]
Kabre, Beniwende [1 ]
Szot, Gregory [1 ]
Calderon, Boris [2 ]
Brekken, Rolf [3 ]
Pullen, Nick [5 ]
Arch, Robert [4 ]
Bluestone, Jeffery [1 ]
机构：
[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[2] Washington Univ, Dept Pathol & Immunol, Dallas, MO USA
[3] UT Southwestern Med Ctr, Div Surg Oncol, Dallas, TX USA
[4] Pfizer Inc, Pfizer Global Res & Dev, Chesterfield, MO USA
[5] Pfizer Inc, Pfizer Global Res & Dev, Cambridge, MA USA
来源：
JOURNAL OF IMMUNOLOGY | 2013年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P5181
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice
    Thébault-Baumont, K
    Dubois-Laforgue, D
    Krief, P
    Briand, JP
    Halbout, P
    Vallon-Geoffroy, K
    Morin, J
    Laloux, V
    Lehuen, A
    Carel, JC
    Jami, J
    Muller, S
    Boitard, C
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06): : 851 - 857
  • [22] Inhibition of Ca2+-Independent Phospholipase A2β (iPLA2β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice
    Bone, Robert N.
    Gai, Ying
    Magrioti, Victoria
    Kokotou, Maroula G.
    Ali, Tomader
    Lei, Xiaoyong
    Tse, Hubert M.
    Kokotos, George
    Ramanadham, Sasanka
    DIABETES, 2015, 64 (02) : 541 - 554
  • [23] The targeted inhibition of neuraminidase reverses endothelial glycocalyx degradation and improves endothelial function in type 2 diabetes
    Foote, Christopher A.
    Ghiarone, Thaysa
    Ramirez-Perez, Francisco I.
    Kluser, Allan R. K.
    Grunewald, Zachary I.
    Jurrissen, Thomas J.
    Brown, Scott M.
    Bender, Shawn B.
    Manrique-Acevedo, Camila
    Aroor, Annayya R.
    Padilla, Jaume
    Martinez-Lemus, Luis A.
    FASEB JOURNAL, 2019, 33
  • [24] Exposure to Bisphenol A Accelerates Diabetes Type 1 Development in NOD Mice via Impaired Macrophage Function
    Bodin, Johanna
    Bolling, Anette Kocbach
    Wendt, Anna
    Son, Lena Elias
    Becher, Rune
    Kuper, Frieke
    Lovik, Martinus
    Nygaard, Unni Cecilie
    DIABETES, 2014, 63 : A648 - A648
  • [25] Modulation of insulitis and type 1 diabetes mellitus in NOD mice lacking MHC class II genes in the presence or absence of HLA DR3
    Kudva, YC
    Abraham, RS
    David, CS
    DIABETES, 2000, 49 : A209 - A209
  • [26] Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens
    Denes, B
    Krausova, V
    Fodor, N
    Timiryasova, T
    Henderson, D
    Hough, J
    Yu, J
    Fodor, I
    Langridge, WHR
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (05) : 438 - 448
  • [27] Inhibition of vascular endothelial growth factor receptor reverses type 1 diabetes in nonobese diabetic mice.
    Villalta, Armando
    Lang, Jiena
    Kabre, Beniwende
    Kubeck, Sam
    Arch, Robert
    Bluestone, Jeff
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [28] β-Cell-Specific IL-2 Therapy Increases Islet Foxp3+Treg and Suppresses Type 1 Diabetes in NOD Mice
    Johnson, Mark C.
    Garland, Alaina L.
    Nicolson, Sarah C.
    Li, Chengwen
    Samulski, R. Jude
    Wang, Bo
    Tisch, Roland
    DIABETES, 2013, 62 (11) : 3775 - 3784
  • [29] Inhibition of CD26/DPP-IV activity reverses new-onset diabetes and prolongs islet graft survival in spontaneously diabetic NOD mice.
    Hao, Jianqiang
    Zhang, Yu
    Tian, Bole
    Sutherland, David E. R.
    Hering, Bernhard J.
    Luo, Jian
    Guo, Zhiguang
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 581 - 581
  • [30] VEGF-conjugated alginate hydrogel prompt angiogenesis and improve pancreatic islet engraftment and function in type 1 diabetes
    Yin, Nina
    Han, Yongming
    Xu, Hanlin
    Gao, Yisen
    Yi, Tao
    Yao, Jiale
    Dong, Li
    Cheng, Dejun
    Chen, Zebin
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2016, 59 : 958 - 964
12345